157 related articles for article (PubMed ID: 20158657)
21. [Antibiotic resistance of community-acquired uropathogenic Enterobacteriaceae isolated in Sfax (Tunisia)].
Smaoui S; Abdelhedi K; Marouane C; Kammoun S; Messadi-Akrout F
Med Mal Infect; 2015 Aug; 45(8):335-7. PubMed ID: 26362517
[No Abstract] [Full Text] [Related]
22. [Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Forestier E; Gros S; Peynaud D; Levast M; Boisseau D; Ferry-Blanco C; Labe A; Lecomte C; Rogeaux O
Med Mal Infect; 2012 Sep; 42(9):440-3. PubMed ID: 22925551
[TBL] [Abstract][Full Text] [Related]
23. Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Mambie A; Vuotto F; Poitrenaud D; Weyrich P; Cannesson O; Dessein R; Faure K; Guery B; Galpérine T
Med Mal Infect; 2016 Jun; 46(4):215-9. PubMed ID: 27210283
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Infect Control Hosp Epidemiol; 2007 Jul; 28(7):873-6. PubMed ID: 17564993
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of antibiotic resistance and genotypes on extended spectrum β-lactamase and AmpC β-lactamase producing strains isolated from Uygur and Han newborns].
Zhang WL; Liu J; Zhang J; Su GL
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):217-24. PubMed ID: 21624232
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
28. Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years.
Sun J; Zheng F; Wang F; Wu K; Wang Q; Chen Q; Yu S; Rui Y
Microb Drug Resist; 2013 Aug; 19(4):289-94. PubMed ID: 23573964
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
[TBL] [Abstract][Full Text] [Related]
30. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
Blot S; Memon JI
Saudi Med J; 2009 Oct; 30(10):1366-7; author reply1366-7. PubMed ID: 19838454
[No Abstract] [Full Text] [Related]
32. Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.
Bitsori M; Galanakis E
Pediatr Infect Dis J; 2019 Dec; 38(12):e332-e335. PubMed ID: 31738343
[No Abstract] [Full Text] [Related]
33. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
[TBL] [Abstract][Full Text] [Related]
34. OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada.
Ellis C; Chung C; Tijet N; Patel SN; Desjardins M; Melano RG; Toye B
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):399-400. PubMed ID: 23711532
[No Abstract] [Full Text] [Related]
35. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic impact of extended-spectrum beta-lactamases (ESBL)].
Cercenado E
Rev Clin Esp; 2011 Mar; 211(3):139-41. PubMed ID: 21367407
[No Abstract] [Full Text] [Related]
37. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
38. Urinary tract infections owing to ESBL-producing bacteria: microorganisms change--clinical pattern does not.
Özçakar ZB; Yalçınkaya F; Kavaz A; Kadıoğlu G; Elhan AH; Aysev D; Güriz H; Ekim M
Acta Paediatr; 2011 Aug; 100(8):e61-4. PubMed ID: 21392102
[TBL] [Abstract][Full Text] [Related]
39. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
[TBL] [Abstract][Full Text] [Related]
40. Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Yilmaz E; Akalin H; Ozbey S; Kordan Y; Sinirtaş M; Gürcüoglu E; Ozakin C; Heper Y; Mistik R; Helvaci S
J Chemother; 2008 Oct; 20(5):581-5. PubMed ID: 19028620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
